Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
lululemon athletica
LULU
|
+$612M |
| 2 |
Danaher
DHR
|
+$490M |
| 3 |
PayPal
PYPL
|
+$468M |
| 4 |
Intuitive Surgical
ISRG
|
+$416M |
| 5 |
XYZ
Block, Inc.
XYZ
|
+$410M |
Top Sells
| 1 |
McDonald's
MCD
|
+$737M |
| 2 |
Goldman Sachs
GS
|
+$721M |
| 3 |
UnitedHealth
UNH
|
+$655M |
| 4 |
JPMorgan Chase
JPM
|
+$560M |
| 5 |
Booking.com
BKNG
|
+$559M |
Sector Composition
| 1 | Technology | 22% |
| 2 | Healthcare | 17.09% |
| 3 | Consumer Discretionary | 16.54% |
| 4 | Financials | 12.14% |
| 5 | Communication Services | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
451
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $7.11M | 0.01% |
+212,466
| New | +$7.11M |
|
452
AnaptysBio
ANAB
$621M
| $7.04M | 0.01% |
96,391
-9
| -0% | -$657 |
|
453
Alcoa
AA
$8.3B
| $7.02M | 0.01% |
249,415
+629
| +0.3% | +$17.7K |
|
454
Cognex
CGNX
$7.55B
| $6.73M | 0.01% |
+132,366
| New | +$6.73M |
|
455
Waste Connections
WCN
$45.9B
| $6.36M | 0.01% |
71,803
+2,844
| +4% | +$252K |
|
456
Spyre Therapeutics
SYRE
$1.03B
| $6.25M | 0.01% |
31,044
-23,028
| -43% | -$4.63M |
|
457
First Solar
FSLR
$21.8B
| $6.22M | 0.01% |
+117,713
| New | +$6.22M |
|
|
PE
458
DELISTED
PARSLEY ENERGY INC
PE
| $6.16M | 0.01% |
+319,324
| New | +$6.16M |
|
|
RDC
459
DELISTED
Rowan Companies Plc
RDC
| $6.12M | 0.01% |
567,597
-67,720
| -11% | -$731K |
|
460
Hudbay
HBM
$5.22B
| $6.11M | 0.01% |
854,169
-514,026
| -38% | -$3.68M |
|
461
Chart Industries
GTLS
$8.96B
| $6M | 0.01% |
+66,273
| New | +$6M |
|
462
Patterson-UTI
PTEN
$2.16B
| $5.75M | 0.01% |
409,864
-443,152
| -52% | -$6.21M |
|
|
BPL
463
DELISTED
Buckeye Partners, L.P.
BPL
| $5.69M | 0.01% |
+167,245
| New | +$5.69M |
|
464
Norfolk Southern
NSC
$61.8B
| $5.64M | 0.01% |
+30,149
| New | +$5.64M |
|
|
FSTX
465
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $5.55M | 0.01% |
132,320
-22
| -0% | -$923 |
|
|
MMP
466
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.23M | 0.01% |
+86,247
| New | +$5.23M |
|
467
Viking Therapeutics
VKTX
$2.87B
| $5.1M | 0.01% |
512,695
-108,094
| -17% | -$1.07M |
|
|
ICD
468
DELISTED
Independence Contract Drilling, Inc.
ICD
| $4.94M | ﹤0.01% |
89,173
-105
| -0.1% | -$5.82K |
|
469
Halliburton
HAL
$18.6B
| $4.92M | ﹤0.01% |
167,922
-274,551
| -62% | -$8.04M |
|
470
Houlihan Lokey
HLI
$14B
| $4.85M | ﹤0.01% |
+105,815
| New | +$4.85M |
|
471
Armstrong World Industries
AWI
$8.52B
| $4.44M | ﹤0.01% |
+55,960
| New | +$4.44M |
|
|
DBVT
472
DBV Technologies
DBVT
$245M
| $4.14M | ﹤0.01% |
53,629
+58
| +0.1% | +$4.47K |
|
|
IMGN
473
DELISTED
Immunogen Inc
IMGN
| $3.99M | ﹤0.01% |
1,471,676
+398,855
| +37% | +$1.08M |
|
474
Amgen
AMGN
$151B
| $3.85M | ﹤0.01% |
+20,286
| New | +$3.85M |
|
|
RNTX
475
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $3.83M | ﹤0.01% |
102,013
+88,404
| +650% | +$3.32M |
|